logo-loader
CVE:LXG

Lexagene Holdings Inc

Market:
CVE
Market Cap:
$35.83 m
Price
0.50 CAD
Change
2.04%
52 weeks high
0.93
52 weeks low
0.45

In brief

LexaGene is a biotechnology company developing a fully automated pathogen detection platform for use at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene’s technology aims to transform the way organizations prevent and diagnose disease in multi-billion dollar markets such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and more.